Quantbot Technologies LP Kura Oncology, Inc. Transaction History

Quantbot Technologies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$17.53 - $22.98 $61,109 - $80,108	-3,486 Reduced 99.6%	14 $0
Q1 2024 May 06, 2024	BUY	$13.42 - $23.53 $46,970 - $82,355	3,500 New	3,500 $74,000
Q4 2021 Feb 11, 2022	SELL	$12.22 - $19.57 $81,874 - $131,119	-6,700 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$15.42 - $21.72 $66,306 - $93,396	-4,300 Reduced 39.09%	6,700 $125,000
Q2 2021 Aug 12, 2021	BUY	$20.85 - $29.88 $133,440 - $191,232	6,400 Added 139.13%	11,000 $229,000
Q1 2021 May 14, 2021	BUY	$24.75 - $39.14 $113,850 - $180,044	4,600 New	4,600 $130,000
Q4 2019 Feb 10, 2020	SELL	$12.97 - $15.94 $29,169 - $35,849	-2,249 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$14.75 - $20.87 $33,172 - $46,936	2,249 New	2,249 $34,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.